GRI Bio, Inc. (NASDAQ:GRI) Financings

GRI Bio, Inc.

Financings

RaiseDate
Public offering of common stock (or common stock equivalents) and Series F warrants
Closed: US$8M raised · US$0.75 a share · Warrants at US$0.75 for 60 months · H.C. Wainwright & Co.
Dealers: H.C. Wainwright & Co. (lead)
Use of proceeds: Product candidate development, working capital and general corporate purposes
Dec 12, 2025
Public offering of shares of common stock (or common stock equivalents) and accompanying Series E-1, E-2 and E-3 warrants
Closed: US$5M raised · US$3.6 a share · Warrants at US$3.2 · H.C. Wainwright & Co.
Dealers: H.C. Wainwright & Co. (lead)
Use of proceeds: Product candidate development, working capital and general corporate purposes
Apr 2, 2025

Read by 6ix AI from the company's releases